![Xiao Dong Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xiao Dong Yang
Fondatore presso Apexigen America, Inc.
Provenienza dei contatti di primo grado di Xiao Dong Yang
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
16
| Public Company | Pharmaceuticals: Major | 16 |
Apexigen America, Inc.
![]() Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Public Company | Biotechnology | 12 | |
Public Company | Miscellaneous Commercial Services | 10 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Xiao Dong Yang tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree | |
Intradigm Corp.
![]() Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman Director/Board Member President Corporate Officer/Principal | |
KITE PHARMA INC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Private Equity Investor | |
NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Michigan State University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer | |
University of Toronto | College/University | Undergraduate Degree Undergraduate Degree | |
New York University | College/University | Doctorate Degree Graduate Degree | |
National Academy of Sciences
![]() National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
American Academy of Arts & Sciences
![]() American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
Zyngenia, Inc.
![]() Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Epitomics, Inc.
![]() Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Indiana University | College/University | Doctorate Degree Doctorate Degree | |
PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
A2 Biotherapeutics, Inc.
![]() A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Refuge Biotechnologies, Inc.
![]() Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
G.D. Searle LLC | Corporate Officer/Principal General Counsel | ||
PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor General Counsel | |
The Schulich School of Business | College/University | Masters Business Admin Masters Business Admin | |
Vasomune Therapeutics, Inc.
![]() Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Fore Biotherapeutics, Inc.
![]() Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Morgan Stanley & Co. LLC
![]() Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal | |
The University of Southampton | College/University | Undergraduate Degree | |
Angiocrine Bioscience, Inc.
![]() Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | Miscellaneous Commercial Services | Director/Board Member | |
The University of Manchester | College/University | Doctorate Degree | |
University of Southern California
![]() University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Director/Board Member | |
W.M. Keck Foundation, Inc.
![]() W.M. Keck Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services W.M. Keck Foundation, Inc. is a charitable foundation which supports scientific, engineering, and medical research. The company was founded by William Myron Keck in 1954 and is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Amherst College | College/University | Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 40 |
Canada | 5 |
Regno Unito | 3 |
Svizzera | 2 |
Italia | 2 |
Settori
Health Technology | 26 |
Consumer Services | 15 |
Commercial Services | 9 |
Retail Trade | 2 |
Finance | 2 |
Posizioni
Director/Board Member | 279 |
Corporate Officer/Principal | 137 |
Chairman | 68 |
Independent Dir/Board Member | 63 |
Chief Executive Officer | 41 |
Contatti più connessi
Insiders | |
---|---|
Jeremy Curnock-Cook | 60 |
James Topper | 52 |
Iain Ross | 41 |
David Parkinson | 31 |
David Goeddel | 27 |
Daniel Zabrowski | 24 |
William J. Rutter | 22 |
Scott Smith | 21 |
Gordon Ringold | 20 |
David Mack | 19 |
Sam Wertheimer | 17 |
Meenu Chhabra Karson | 17 |
Linda Rubinstein | 16 |
David Chang | 16 |
Robert Bradway | 14 |
- Borsa valori
- Insiders
- Xiao Dong Yang
- Connessioni Società